Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 30718231

Clinical responses and persistent BRAF V600E(+) blood cells in children with LCH treated with MAPK pathway inhibition.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2019 Apr 11
First author
Eckstein OS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2010 Sep 16;116(11):1919-23. doi: 10.1182/blood-2010-04-279083.
    note
    Source null
    related pmid
    20519626
    relationship
    Comment on

Authors and identifiers

  1. name
    Eckstein OS
    type
    Author
  2. name
    Visser J
    type
    Author
  3. name
    Rodriguez-Galindo C
    type
    Author
  4. name
    Allen CE
    type
    Author
  5. name
    NACHO-LIBRE Study Group
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Eckstein OS
    type
    Author
  2. name
    Visser J
    type
    Author
  3. name
    Rodriguez-Galindo C
    type
    Author
  4. name
    Allen CE
    type
    Author
  5. name
    NACHO-LIBRE Study Group
    type
    CollectiveName
bibliography ids
  1. nci-bib-054ae74915d8e141b62dea5f
book metadata
content sha256
fd5ad191cc7f1ed8481aba90e195cc80423a3fc677ea180fa8332dc1789f6a95
document type
citation
dois
  1. 10.1182/blood-2018-10-878363
electronic publication date
display
2019 Feb 4
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30718231
immutable id
pubmed:30718231@fd5ad191cc7f1ed8481aba90e195cc80423a3fc677ea180fa8332dc1789f6a95
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
15
name
Blood
nlm unique id
7603509
pages
1691-1694
volume
133
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2010 Sep 16;116(11):1919-23. doi: 10.1182/blood-2010-04-279083.
    note
    Source null
    related pmid
    20519626
    relationship
    Comment on
outcomes validated
false
pmid
30718231
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
aa69a5344f1dd03570ff4ed85b6307fe122359e80253d273b7d119d5dfc831d9
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Apr 11
precision
day
year
2019
publication types
  1. Letter
  2. Research Support, N.I.H., Extramural
  3. Research Support, Non-U.S. Gov't
  4. Comment
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30718231/
title
Clinical responses and persistent BRAF V600E(+) blood cells in children with LCH treated with MAPK pathway inhibition.

Preserved source evidence · Independent clinical review pending · Not medical advice